| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Severe Combined Immunodeficiency | 7 | 2018 | 106 | 0.940 |
Why?
|
| Granuloma | 2 | 2021 | 63 | 0.590 |
Why?
|
| Bronchiectasis | 1 | 2019 | 22 | 0.590 |
Why?
|
| Granulomatous Disease, Chronic | 5 | 2020 | 70 | 0.570 |
Why?
|
| DiGeorge Syndrome | 6 | 2015 | 81 | 0.570 |
Why?
|
| Sinusitis | 1 | 2019 | 116 | 0.550 |
Why?
|
| B-Lymphocytes | 3 | 2018 | 529 | 0.490 |
Why?
|
| Killer Cells, Natural | 3 | 2016 | 344 | 0.480 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2016 | 75 | 0.480 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2014 | 7 | 0.440 |
Why?
|
| Molluscum Contagiosum | 1 | 2014 | 11 | 0.440 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 496 | 0.430 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2014 | 13 | 0.430 |
Why?
|
| Mucous Membrane | 1 | 2014 | 88 | 0.430 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2023 | 1263 | 0.410 |
Why?
|
| Immunologic Deficiency Syndromes | 5 | 2021 | 210 | 0.400 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 272 | 0.380 |
Why?
|
| Skin | 1 | 2014 | 553 | 0.340 |
Why?
|
| Skin Tests | 3 | 2025 | 100 | 0.320 |
Why?
|
| Cord Blood Stem Cell Transplantation | 2 | 2023 | 58 | 0.320 |
Why?
|
| Common Variable Immunodeficiency | 2 | 2008 | 31 | 0.320 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 389 | 0.310 |
Why?
|
| Lymphopenia | 2 | 2023 | 34 | 0.310 |
Why?
|
| Immunoglobulin E | 3 | 2025 | 225 | 0.310 |
Why?
|
| Transplantation Conditioning | 3 | 2017 | 329 | 0.300 |
Why?
|
| Rubella | 2 | 2021 | 19 | 0.290 |
Why?
|
| Brain Abscess | 1 | 2008 | 54 | 0.270 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2006 | 9 | 0.240 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2006 | 21 | 0.240 |
Why?
|
| Spirometry | 2 | 2022 | 90 | 0.230 |
Why?
|
| T-Lymphocytes | 5 | 2009 | 1788 | 0.230 |
Why?
|
| Antigens, Plant | 1 | 2025 | 45 | 0.220 |
Why?
|
| Peanut Hypersensitivity | 1 | 2025 | 89 | 0.200 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 569 | 0.200 |
Why?
|
| Epitopes | 1 | 2025 | 432 | 0.200 |
Why?
|
| Autoimmune Diseases | 2 | 2018 | 275 | 0.190 |
Why?
|
| Rubella virus | 1 | 2021 | 5 | 0.180 |
Why?
|
| Humans | 39 | 2025 | 131680 | 0.170 |
Why?
|
| Racism | 1 | 2022 | 43 | 0.170 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 159 | 0.170 |
Why?
|
| Neutrophils | 2 | 2021 | 372 | 0.170 |
Why?
|
| Unrelated Donors | 2 | 2018 | 71 | 0.160 |
Why?
|
| Health Equity | 1 | 2022 | 79 | 0.160 |
Why?
|
| Allergens | 2 | 2025 | 356 | 0.160 |
Why?
|
| Mutation | 4 | 2018 | 6177 | 0.140 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2018 | 48 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2018 | 32 | 0.140 |
Why?
|
| Child | 18 | 2025 | 26299 | 0.140 |
Why?
|
| Cough | 1 | 2019 | 99 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2022 | 400 | 0.140 |
Why?
|
| Alemtuzumab | 1 | 2018 | 89 | 0.140 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 25 | 0.140 |
Why?
|
| Child, Preschool | 14 | 2025 | 15057 | 0.130 |
Why?
|
| Macrophages | 1 | 2021 | 666 | 0.130 |
Why?
|
| Female | 21 | 2025 | 71186 | 0.130 |
Why?
|
| Infant | 13 | 2025 | 13306 | 0.130 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2017 | 14 | 0.130 |
Why?
|
| Leukopenia | 1 | 2017 | 45 | 0.130 |
Why?
|
| Male | 22 | 2025 | 65267 | 0.130 |
Why?
|
| Adolescent | 13 | 2025 | 20982 | 0.120 |
Why?
|
| rab27 GTP-Binding Proteins | 1 | 2016 | 5 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 119 | 0.120 |
Why?
|
| Polymorphism, Genetic | 2 | 2018 | 794 | 0.110 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2014 | 27 | 0.110 |
Why?
|
| Chickenpox | 1 | 2014 | 22 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2018 | 184 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 636 | 0.110 |
Why?
|
| Chromosome Disorders | 1 | 2017 | 315 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 1226 | 0.110 |
Why?
|
| Telomere Shortening | 1 | 2014 | 35 | 0.110 |
Why?
|
| Inflammation | 1 | 2021 | 1492 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2025 | 2143 | 0.110 |
Why?
|
| Osteomyelitis | 2 | 2007 | 212 | 0.100 |
Why?
|
| Siblings | 1 | 2014 | 204 | 0.100 |
Why?
|
| Asthma | 1 | 2022 | 927 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2014 | 202 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2021 | 3695 | 0.090 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 803 | 0.090 |
Why?
|
| Heterozygote | 1 | 2014 | 728 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2016 | 929 | 0.090 |
Why?
|
| Cognition | 1 | 2017 | 845 | 0.090 |
Why?
|
| Lymphocyte Count | 3 | 2009 | 120 | 0.080 |
Why?
|
| Autoimmunity | 1 | 2011 | 182 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 1958 | 0.080 |
Why?
|
| Rotavirus Vaccines | 1 | 2010 | 60 | 0.080 |
Why?
|
| Vaccination | 1 | 2014 | 1040 | 0.070 |
Why?
|
| Hematopoietic System | 1 | 2008 | 7 | 0.070 |
Why?
|
| Adenylate Kinase | 1 | 2008 | 12 | 0.070 |
Why?
|
| Interleukin-7 | 1 | 2009 | 46 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2021 | 643 | 0.070 |
Why?
|
| Antigens, Fungal | 1 | 2008 | 34 | 0.070 |
Why?
|
| Tetanus Toxoid | 1 | 2008 | 48 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1613 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 216 | 0.070 |
Why?
|
| HIV Infections | 2 | 1997 | 2037 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 116 | 0.070 |
Why?
|
| Candida | 1 | 2008 | 79 | 0.070 |
Why?
|
| ROC Curve | 2 | 2021 | 615 | 0.070 |
Why?
|
| Basidiomycota | 1 | 2007 | 11 | 0.070 |
Why?
|
| Rotavirus Infections | 1 | 2010 | 281 | 0.070 |
Why?
|
| CD3 Complex | 2 | 2008 | 90 | 0.070 |
Why?
|
| Rotavirus | 1 | 2010 | 366 | 0.070 |
Why?
|
| Adult | 9 | 2018 | 31719 | 0.060 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2008 | 155 | 0.060 |
Why?
|
| Phenotype | 1 | 2017 | 4516 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2021 | 5123 | 0.060 |
Why?
|
| Middle Aged | 4 | 2021 | 28889 | 0.060 |
Why?
|
| Allografts | 2 | 2017 | 209 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 320 | 0.060 |
Why?
|
| Radioallergosorbent Test | 1 | 2006 | 9 | 0.060 |
Why?
|
| Phytohemagglutinins | 2 | 2003 | 12 | 0.060 |
Why?
|
| Mycoses | 1 | 2007 | 110 | 0.060 |
Why?
|
| Burkholderia gladioli | 1 | 2005 | 2 | 0.060 |
Why?
|
| Burkholderia Infections | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cytokines | 2 | 2021 | 1348 | 0.060 |
Why?
|
| 2S Albumins, Plant | 1 | 2025 | 6 | 0.060 |
Why?
|
| Radiography | 2 | 2017 | 762 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 910 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 485 | 0.050 |
Why?
|
| Arachis | 1 | 2025 | 76 | 0.050 |
Why?
|
| Th2 Cells | 2 | 2021 | 186 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 837 | 0.050 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2023 | 12 | 0.050 |
Why?
|
| src Homology Domains | 1 | 2023 | 35 | 0.050 |
Why?
|
| Busulfan | 1 | 2023 | 49 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 3413 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2003 | 49 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2025 | 6494 | 0.050 |
Why?
|
| CD8 Antigens | 1 | 2003 | 39 | 0.050 |
Why?
|
| Immunization | 1 | 2004 | 307 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2025 | 344 | 0.050 |
Why?
|
| Survival Rate | 2 | 2017 | 2151 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 226 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2021 | 25 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 934 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2022 | 176 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2022 | 58 | 0.040 |
Why?
|
| Reference Values | 1 | 2003 | 692 | 0.040 |
Why?
|
| Cell Division | 1 | 2003 | 731 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2001 | 26 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 2001 | 36 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2004 | 317 | 0.040 |
Why?
|
| Job Syndrome | 1 | 2001 | 18 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2022 | 220 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5297 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2008 | 2463 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 442 | 0.040 |
Why?
|
| Chemokines | 1 | 2001 | 127 | 0.040 |
Why?
|
| Arginine | 1 | 2023 | 344 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 320 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 283 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2021 | 396 | 0.040 |
Why?
|
| DNA Copy Number Variations | 2 | 2016 | 1023 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 306 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2297 | 0.040 |
Why?
|
| Pedigree | 2 | 2016 | 1710 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2018 | 8589 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 1517 | 0.040 |
Why?
|
| Complement Hemolytic Activity Assay | 1 | 1998 | 1 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2018 | 160 | 0.040 |
Why?
|
| Immunologic Tests | 1 | 1998 | 17 | 0.030 |
Why?
|
| Chimerism | 1 | 2018 | 29 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1610 | 0.030 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1998 | 32 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2021 | 493 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 1998 | 64 | 0.030 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 33 | 0.030 |
Why?
|
| Pancytopenia | 1 | 2018 | 41 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 338 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2018 | 187 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1998 | 102 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 464 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1998 | 159 | 0.030 |
Why?
|
| Communication | 1 | 2022 | 531 | 0.030 |
Why?
|
| Adenylyl Cyclases | 1 | 2017 | 61 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 10104 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 382 | 0.030 |
Why?
|
| Machine Learning | 1 | 2021 | 375 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 2017 | 136 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1997 | 132 | 0.030 |
Why?
|
| Phagocytosis | 1 | 1998 | 191 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2017 | 87 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2017 | 17667 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1260 | 0.030 |
Why?
|
| Piebaldism | 1 | 2016 | 3 | 0.030 |
Why?
|
| Albinism | 1 | 2016 | 8 | 0.030 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 329 | 0.030 |
Why?
|
| Micronutrients | 1 | 1996 | 61 | 0.030 |
Why?
|
| Sepsis | 1 | 2020 | 501 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 21261 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 810 | 0.030 |
Why?
|
| Consanguinity | 1 | 2016 | 119 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2015 | 11 | 0.030 |
Why?
|
| Age of Onset | 1 | 2017 | 632 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 264 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2016 | 201 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2017 | 570 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 10959 | 0.030 |
Why?
|
| Immunological Synapses | 1 | 2015 | 32 | 0.030 |
Why?
|
| Integrins | 1 | 2015 | 90 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 410 | 0.030 |
Why?
|
| Nutritional Status | 1 | 1996 | 302 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 230 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 1069 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2015 | 266 | 0.030 |
Why?
|
| United States | 2 | 2022 | 11804 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 773 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1565 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2017 | 650 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2021 | 810 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3454 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2001 | 2357 | 0.020 |
Why?
|
| Texas | 1 | 2021 | 3622 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1997 | 1911 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1712 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2206 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 1008 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 680 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 3347 | 0.020 |
Why?
|
| Diarrhea, Infantile | 1 | 2010 | 31 | 0.020 |
Why?
|
| Dehydration | 1 | 2010 | 41 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1392 | 0.020 |
Why?
|
| Virus Shedding | 1 | 2010 | 75 | 0.020 |
Why?
|
| Exome | 1 | 2014 | 1076 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2010 | 88 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7572 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 210 | 0.020 |
Why?
|
| Ear, Inner | 1 | 2008 | 42 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 595 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2010 | 451 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 236 | 0.020 |
Why?
|
| Genomics | 1 | 2016 | 1625 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2010 | 513 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 240 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 362 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2008 | 200 | 0.020 |
Why?
|
| Sacrum | 1 | 2007 | 28 | 0.020 |
Why?
|
| Voriconazole | 1 | 2007 | 30 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2007 | 35 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 28 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2007 | 49 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1236 | 0.020 |
Why?
|
| Echinocandins | 1 | 2007 | 42 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1078 | 0.020 |
Why?
|
| Triazoles | 1 | 2007 | 143 | 0.020 |
Why?
|
| Feces | 1 | 2010 | 725 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 427 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2007 | 298 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 2694 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2009 | 681 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 1745 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2007 | 443 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2005 | 386 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 2605 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2004 | 336 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 432 | 0.010 |
Why?
|
| Animals | 2 | 2018 | 34375 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 769 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2009 | 12984 | 0.010 |
Why?
|
| Chemokine CCL7 | 1 | 2001 | 7 | 0.010 |
Why?
|
| Chemokine CXCL5 | 1 | 2001 | 6 | 0.010 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2001 | 7 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 2001 | 12 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2001 | 59 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2001 | 43 | 0.010 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2001 | 20 | 0.010 |
Why?
|
| Receptor, trkA | 1 | 2001 | 18 | 0.010 |
Why?
|
| Osteopontin | 1 | 2001 | 51 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1947 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2001 | 124 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 436 | 0.010 |
Why?
|
| Interleukins | 1 | 2001 | 121 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2001 | 156 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2001 | 207 | 0.010 |
Why?
|
| Quality of Life | 1 | 2009 | 2118 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2001 | 542 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 3101 | 0.010 |
Why?
|
| Vitamin A Deficiency | 1 | 1996 | 11 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2971 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2568 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1996 | 184 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 4050 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 2567 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 18488 | 0.010 |
Why?
|